Member Info for GETINTHERE

And having posted that - they’ve all appeared again !

Maybe it’s my phone or some quirk, whatever it is it’s blimmin weird !

Hey ho never mind, we are another day closer to template production ;-)

And at the time of writing all of today’s posts are missing from the chat page !

Deal3r

Yes, we worked that out yesterday the site I got the information from seems to be wrong, another site quoted an average of 24, which seems far more realistic.

Mickb

Thanks for the explanation and link it’s good to know how these things work, albeit that I still don’t understand why a trade that happened on Friday wasn’t shown until Tuesday, but hey ho, the only thing that really matters is that production continues to increase and that we finally hit our targets ;-)

A buy of Over 300,000 reported this morning dated last Friday - I don’t understand why it’s taken two working days to report it !

Good morning Mullins

Thanks for posting an interview with real facts, I have no doubt that the few constantly negative posters won’t appreciate it, but I do, as it’s good to be reminded of where we are now rather than the past.

Dreamy

I’m glad you are still alive and kicking mate ;-)

Our wait continues but as you say July appeared to be a step in the right direction - let’s hope so anyway.

Prion25

If SNG receives approval, as I believe they will, then the SP will be many multiples of today’s price and all of us that are invested will make money, but, more importantly, many lives will be saved.

Let’s hope that phase 3 is as successful as phase 2 ;-)

Doc83

Yes to be fair another site says the average is 24, which seems far more realistic.

Doc83

This is where I got the PE ratio for pharmaceutical companies from, as you will see both the trailing and forward PE ratios for drug companies are above 85 mate.

https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/

Prion

If the figure of £146.5 million in sales for 2021 becomes reality and then the figure of £583 million becomes reality for 2022 as in the article that you posted, then the SP for SNG will be massive.

The average PE ratio for pharmaceutical companies is circa 80, so even if earnings were only 10% of sales that’s £14.65 million x 80 = £1,172,000,000 divided by the 200 million shares in issue = £5.86 per share and if we use 10% and apply it to the forecast for 2022 of £583 million we get £58.3 million x 80 = 4,664,000,000 divided by 200 million shares in issue = £23.32 per share.

Of course earnings may well be considerably more than 10% of sales, if they were 20% then you can double the prospective share prices above, so you can see why some people posting here believe that £50 a share is possible.

Safety

LME has tin at $33,693 for cash and $33,100 for the 3 month contract price mate, both well above shards $23,000 average ;-) the 15 month contract price is $31,240 and that’s still 35.82% above shards price ;-)

We continue our wait, but as each week passes our production levels increase and in the months to come our patience will be rewarded.

Have a great weekend, our time will come ;-)

Safety

Fruition would be good mate - particularly as so far all we’ve had is frustration ;-)

MIB - eventually may eventually become a concern to me too mate ;-)

Safety - I’m far to far underwater to be out of these over the weekend ;-)

OMR - hang in there mate, I’ve got a few years to go before I get my state pension and the buglers are talking about stopping the triple lock, which will mean that we all get less :-(

Oh well 42.32% above the forecast is still pretty good ;-)

Oh, and tungsten is still above $300 per mtu

High metal prices plus Increasing production, increasing recoveries, and increasing utilisation will eventually lead to an increasing SP ;-)

Tungsten is still above $300 per mtu and tin is just under $36,000 per ton, which is great news at a time when we are ramping up towards template production.

Things are going in the right direction at long, long, last ;-)

Troajan

Who said that MM only holds 6% ?

From the annual report:-

Financial



· In October 2020, Synairgen raised £87.1 million (before expenses) in an equity issue to fund SG018 Phase III trial, SNG001 manufacturing, regulatory activities, and to strengthen balance sheet



· In March 2020, Synairgen raised £14.0 million (before expenses) in an equity issue to fund initial COVID-19 clinical trial activity



· The loss from operations for the year ended 31 December 2020 was £17.7 million (2019: £4.8 million), with research and development expenditure amounting to £15.5 million (2019: £3.5 million)

- £12.0 million year-on-year increase on research and development expenditure attributable to COVID-19 activities



· Cash balances of £75.0 million at 31 December 2020 (31 December 2019: £2.5 million)

Bermudarun

Does it say if it’s the Chinese price or the European price mate ? Or do they just give a price ?